Increased arterial intima-media thickness in childhood-onset growth hormone deficiency

被引:132
作者
Capaldo, B
Patti, L
Oliviero, U
Longobardi, S
Pardo, F
Vitale, F
Fazio, S
DiRella, F
Biondi, B
Lombardi, G
Sacca, L
机构
[1] UNIV NAPLES FEDERICO II, DEPT INTERNAL MED, NAPLES, ITALY
[2] UNIV NAPLES FEDERICO II, DEPT ENDOCRINOL, NAPLES, ITALY
关键词
D O I
10.1210/jc.82.5.1378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Very little is known about the atherosclerotic risk in patients with childhood-onset growth hormone deficiency (GHD). Such data may be relevant to reconstructing the natural course of the cardiovascular abnormalities associated with GHD. To this end, the intima-media thickness (IMT) of the carotid arteries and the vascular risk factors were evaluated in 14 childhood-onset GHD patients (age 25 +/- 1 yr, BMI 22 +/- 0.6 Kg/m(2)) and in 14 age-, sex-, and BMI-matched control subjects. IMT was greater in GHD patients (0.83 +/- 0.06 and 0.81 +/- 0.06 mmol/L for the right and left carotid artery) than in controls (0.64 +/- 0.03 and 0.64 +/- 0.04 mmol/L, P < 0.01 and P < 0.02, respectively). Serum total and lipoprotein cholesterol, and serum total triglycerides did not differ between the two groups. However, a significant increase in low density Lipid triglycerides was present in GHD patients (0.27 +/- 0.02 mmol/L) compared with controls (0.19 +/- 0.01; P = 0.007). No difference was found in plasma fibrinogen and serum Lp(a) levels. Plasma glucose and insulin concentrations were similar in GHD and control subjects both in the fasted state and after an oral glucose load. In conclusion, young patients with childhood-onset GHD show an increased IMT in the absence of clear-cut abnormalities of the classic vascular risk factors. This suggests a role for GH deficiency per se in increasing the atherosclerotic risk.
引用
收藏
页码:1378 / 1381
页数:4
相关论文
共 31 条
[1]  
ALFORD F, 1994, ENDOCRINOL METAB SB, P27
[2]  
[Anonymous], 1980, TECHN REP SER WHO
[3]   Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency - A double-blind, placebo-controlled study [J].
Boger, RH ;
Skamira, C ;
BodeBoger, SM ;
Brabant, G ;
Muhlen, AVZ ;
Frolich, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2706-2713
[4]   Relation of intima-media thickness to atherosclerotic plaques in carotid arteries - The vascular aging (EVA) study [J].
BonithonKopp, C ;
Touboul, PJ ;
Berr, C ;
Leroux, C ;
Mainard, F ;
Courbon, D ;
Ducimetiere, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (02) :310-316
[5]   EFFECTS OF PICOTAMIDE, AN ANTITHROMBOXANE AGENT, ON CAROTID ATHEROSCLEROTIC EVOLUTION - A 2-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN DIABETIC-PATIENTS [J].
COCOZZA, M ;
PICANO, T ;
OLIVIERO, U ;
RUSSO, N ;
COTO, V ;
MILANI, M .
STROKE, 1995, 26 (04) :597-601
[6]   GROWTH-HORMONE TREATMENT IMPROVES SERUM-LIPIDS AND LIPOPROTEINS IN ADULTS WITH GROWTH-HORMONE DEFICIENCY [J].
CUNEO, RC ;
SALOMON, F ;
WATTS, GF ;
HESP, R ;
SONKSEN, PH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (12) :1519-1523
[7]   SERUM-LIPID LEVELS IN GROWTH HORMONE-DEFICIENT MEN [J].
DEBOER, H ;
BLOK, GJ ;
VOERMAN, HJ ;
PHILLIPS, M ;
SCHOUTEN, JA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (02) :199-203
[8]   FIBRINOGEN [J].
ERNST, E .
BRITISH MEDICAL JOURNAL, 1991, 303 (6803) :596-597
[9]   ENHANCEMENT OF CHOLINERGIC TONE BY PYRIDOSTIGMINE PROMOTES BOTH BASAL AND GROWTH-HORMONE (GH)-RELEASING HORMONE-INDUCED GH SECRETION IN CHILDREN OF SHORT STATURE [J].
GHIGO, E ;
MAZZA, E ;
IMPERIALE, E ;
RIZZI, G ;
BENSO, L ;
MULLER, EE ;
CAMANNI, F ;
MASSARA, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :452-456
[10]  
GILAID I, 1977, LANCET, V2, P278